ArticlePharmaceutics2022

Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach.

Hyeon-A Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.